CorporateCapital Allocation Event2026-05-22🇺🇸
Sidewinder Therapeutics closes $137 million Series B funding round
source: Sidewinder Therapeutics
On 2026-05-22, San Diego-based Sidewinder Therapeutics announced the closing of an oversubscribed $137 million Series B financing round. The round was co-led by Frazier Life Sciences and Novartis Venture Fund, with participation from other healthcare investors, to support clinical development of its precision cancer therapies.
0.22Significance4.0Magnitude0.2Systemic0.3Market1Articles
Location
San DiegoCaliforniaNorth AmericaUnited StatesNorth America32.716, -117.161
Story Links